SCHEMBL8287404

SCHEMBL8287404

COCCNCc1ccnc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.38
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 1/20 0.35
KCNH3 Q9ULD8 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK10 P53779 1/20 0.34
CDK4 P11802 2/20 0.34
CCND1 P24385 2/20 0.34
CCND2 P30279 2/20 0.34
CCND3 P30281 2/20 0.34
CYP1A2 P05177 4/20 0.33
LMNA P02545 3/20 0.33
PDCD1 Q15116 2/20 0.33
CD274 Q9NZQ7 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
MAPK1 P28482 1/20 0.33
GSK3B P49841 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286100 0.84 PDE11A (0.43) PDE11AKDM4EALDH1A1MAPTHPGD
SCHEMBL8287411 0.82 PDE11A (0.41) PDE11ACDK4CCND1CCND2CCND3
SCHEMBL5871965 0.80 PDE11A (0.43) PDE11AKDM4EALDH1A1HPGDMAPK8
SCHEMBL5872095 0.80 PDE11A (0.43) PDE11AALDH1A1MAPTHPGDCDK4
SCHEMBL8286099 0.80 PDE11A (0.41) PDE11AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8286191 0.77 KCNH3 (0.37) PDE11AKDM4EALDH1A1MAPTHPGD
SCHEMBL5872390 0.77 PDE11A (0.45) PDE11AKDM4EALDH1A1HPGDMAPK8
SCHEMBL8287353 0.77 CYP19A1 (0.47) PDE11AMAPTCYP1A2CYP3A4
SCHEMBL5872134 0.76 PDE11A (0.42) PDE11AKDM4EALDH1A1CDK4LMNA
SCHEMBL8285202 0.74 NCF1 (0.47) PDE11AKDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed